ATTENTION ALL CUSTOMERS: Due to a recent change of our website, the process for submitting refill requests online has now changed. Please click on “Sign Up Today!†to create a new account, and be sure to download our NEW Mobile app! Thank you for your patience during this transition
Experimental Drug Shows Promise in Slowing Disability from Multiple Sclerosis
Results of a phase 3 clinical trial show an experimental drug called tolebrutinib can delay disability in patients with non-relapsing secondary progressive multiple sclerosis.
Health News is provided as a service to Smith Drug Company site users by HealthDay. Smith Drug Company nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.